Ten23 health, a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (“CDMO”), backed by 3i Group, has acquired all shares in swissfillon, an FDA and Swissmedic approved drug product-focused CDMO active
Tags :Florian Schnyder
Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
The Pestalozzi team included Beat Schwarz (Partner - Corporate / M&A - pictured), Florian Schnyder (Associate - Corporate / M&A), Raphael Widmer (Associate - Corporate / M&A), Hannes F. Baumgartner (Associate - Corporate / M&A),
The team included: partners Franz Schubiger (Corporate / M&A, Life Sciences - pictured), Nils Harbeke (Tax), associate Florian Schnyder (Corporate / M&A), senior associate Lukas Rusch (Litigation & Arbitration), Manuela Morel (Corporate Services).
